Bibliography
- Jabbour SA, Hardy E, Sugg J, Parikh S. Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicentre, randomized, double-blind, placebo-controlled study. Diabetes Care 2014;37:740-50
- Doggrell SA, Tuli R. Dapagliflozin – do we need it registered for type 2 diabetes? Expert Opin Pharmacother 2014;15:1631-5
- Garber AJ, Duncan TG, Goodman AM, et al. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med 1997;103:491-7
- Levy J, Cobas RA, Gomes M. Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2010;2:16
- Aschner P, Chan J, Owens DR, et al. Insulin glargine versus sitagliptin in insulin-naïve patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial. Lancet 2012;379:2262-9
- Doggrell SA. Clinical trials with thiazolidinediones in subjects with Type 2 diabetes – is pioglitazone any different from rosiglitazone? Expert Opin Pharmacother 2008;9:405-20